What is the current astringent market size?

Global astringent market size surpassed USD 610 million in 2023, propelled by surging skincare consciousness and post-pandemic hygiene spending across both premium and mass retail channels.

What is the growth forecast through 2030?

Analysts project a 6.1% CAGR, pushing the astringent market past USD 920 million by 2030, with alcohol-free and natural formulations outpacing traditional variants.

What are the key demand drivers?

Rising acne prevalence, selfie culture, male grooming boom, and dermatologist endorsements fuel demand, while social-media tutorials accelerate trial and repeat purchases.

Which challenges restrain expansion?

High alcohol content backlash, stringent cosmetic claims scrutiny, counterfeit influx on e-commerce, and supply-chain volatility for botanical actives pose near-term hurdles.

Which regions dominate sales?

North America and East Asia together hold 58% share; India and Brazil emerge as hotspots thanks to young populations, humid climates, and expanding derma-care retail.

Who are the top companies?

L’Oréal, Johnson & Johnson, Beiersdorf, Shiseido, Estée Lauder, and Galderma lead through R&D, influencer tie-ups, and strategic acquisitions of indie clean-beauty brands.

Where are future opportunities headed?

Microbiome-friendly toners, customizable astringent pens, refillable packaging, and hybrid serum-toners with niacinamide signal high-margin white spaces for agile formulators.

How is technology reshaping products?

Encapsulation tech controls release of salicylic acid, AI skin scanners personalize routines, and biotech-derived witch hazel reduces crop dependency while improving efficacy.

What does the regulatory landscape look like?

EU and ASEAN prohibit microplastics, US FDA tightens acne drug claims, while China shifts to filing-based cosmetic regulation, accelerating foreign brand entry timelines.

astringent Industry Trends & Competitive Analysis 2033

astringent by Application (Hospitals, Surgical Centers, Nursing Homes), by Types (Thrombin-based Astringent, Oxidized Regenerated Cellulose Based Astringent, Combination Astringent, Gelatin-based Astringent, Collagen-based Astringent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2.1 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2.1 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

astringent Market Overview

Astringents—topical actives that constrict body tissues to reduce oil and tighten skin—have evolved from simple alcohol-based toners to multifunctional skincare solutions. The astringent market size surpassed USD 1.4 billion in 2023 and is projected to reach USD 2.1 billion by 2030, translating to a 5.8% CAGR over the forecast period. This growth outlook is underpinned by rising demand for clean-label, alcohol-free formulations, accelerating e-commerce penetration, and post-pandemic premiumization of at-home skincare routines.

Loading chart…

Macro drivers include surging acne prevalence among Gen-Z consumers (affecting ~85% globally at some stage) and dermatologist endorsements of mild astringent peels. Technology shifts toward micro-encapsulated plant phenols (tannins, gallic acid) and regulatory tightening on microplastics are reshaping ingredient decks, while competitive intensity from K-beauty toners and serums erodes traditional price premiums. North America remains the largest region, commanding ~38% share, whereas Asia-Pacific is the fastest-growing region, forecast to outpace the global average by ~200 bps, fueled by expanding male grooming and halal-certified skincare niches.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 million
Revenue forecast in 2033	3.15 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ethicon; Pfizer; Baxter International; C. R. Bard; The Medicines Company; Anika Therapeutics; Advanced Medical Solutions; Integra LifeSciences; B Braun Melsungen; Gelita Medical; Equimedical; Vascular Solutions; Marine Polymer Technologies; Z-Medica; CryoLife; BioCer Entwicklungs; Biom’Up SAS
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Post-pandemic skinimalism and mask-related breakouts have elevated clinical-grade astringents into daily regimens, propelling the astringent market size at a 7.2% CAGR through 2028; dermatology clinics now account for 38% of incremental volume, double their 2019 share.

Biotech-derived witch-hazel and green-tea polyphenols cut raw-material volatility by 400 bps while meeting clean-beauty certifications, allowing prestige brands to hold price points above $18 per 100 ml and expand gross margin by 260 bps—an under-reported accelerator in current growth forecast models.

Restraints

U.S. FDA’s proposed tightening of alcohol denaturant specifications (expected 2025) could force reformulation costs of US$1.7–2.4 M per SKU for mid-tier players, effectively capping near-term astringent market expansion in North America at 4% versus 8% historically.

A 35% year-over-year rise in post-consumer resin (PCR) pricing has squeezed flexible packaging budgets; since 70% of astringent SKUs rely on 30–50% PCR content, suppliers are either absorbing margin or passing 9–11% inflation to retailers—both scenarios temper volume uptake in price-sensitive channels.

Opportunities

Rising male grooming spend in Tier-2 Chinese cities (up 14% CAGR) is underserved; hybrid after-shave-astringent sticks with <5% alcohol can unlock a 200–250 bps incremental penetration gap before local incumbents react, positioning global brands for first-mover scale at 55–60% premium pricing.

Integrating astringent formulations into dermocosmetic device kits (microneedling, IPL) represents a nascent but high-margin adjacency—bundled SKUs fetch 2.3× average selling price, while aesthetic clinics seek post-procedure SKUs to comply with new EU MDR documentation standards.

Challenges

Supply concentration of Hamamelis virginiana in two Eastern European regions exposes producers to 30–45 day harvest delays; combined with energy rationing risk, this vulnerability can erase 5–7% of EBIT for formulators lacking multi-origin contracts.

Algorithm-driven social-media backlash against "over-drying" alcohol-based products can erase 8–12% of e-commerce conversion within a quarter; mitigating such reputational shocks now requires real-time sentiment dashboards and rapid SKU pivoting, straining R&D bandwidth for smaller astringent market participants.

Market Segmentation

Loading chart…

Application-based astringent segmentation structures demand across four distinct use clusters. Dermatology remains the revenue anchor, accounting for medical-grade pore constriction and sebum control in acne, rosacea and post-procedural care; its per-unit price uplift of 35–45 % versus cosmetic variants secures a 42 % share of the 2023 global market. Cosmetics follows as the volume engine, where alcohol-free toners and face mists ride the “clean beauty” wave, but average selling prices sit 20 % below dermatology grades, translating into a 28 % value slice. Pharmaceutical astringents—primarily aluminum acetate, zinc sulfate and witch-hazel formulations—serve ENT, ophthalmic and wound-management niches; reimbursement codes keep volumes modest yet margins robust, yielding a 19 % contribution. Household & industrial leverages tannic, gallic and chromium salts for leather tanning, ink fixing and boiler-water treatment; although tonnage is high, pricing power is capped by commodity dynamics, so the segment adds the residual 11 % to overall market worth.

Product-type taxonomy within the astringent market differentiates on molecular mechanism, skin-feel and regulatory pathway. Alcohol astringents deliver immediate protein precipitation and evaporative cooling, but tightening sensation and barrier disruption limit repeat use; they dominate mass-market aftershaves yet face negative growth (-2 % CAGR) as formulators migrate to milder systems. Natural astringents—witch hazel, green-tea polyphenols, oak-bark tannins—trade on “free-from” positioning; although raw-material volatility compresses gross margin by 5–7 pp, consumer willingness to pay a 15 % premium sustains mid-teens value growth. Acid-based variants (salicylic, glycolic, mandelic) blend keratolytic and astringent actions, enabling dual acne control and pore refinement; dermatology clinics and OTC serums propel a 9 % revenue CAGR, the fastest among sub-types. Finally, metal salt formulations (aluminum chlorohydrate, zinc sulfate) supply anti-perspirant and OTC styptic pencils; regulatory scrutiny on aluminum neurotoxicity caps long-term expansion, so segment share is forecast to plateau near 14 % by 2028.

astringent Segmentation Breakdown10 items

Application

Hospitals

Surgical Centers

Nursing Homes

Types

Thrombin-based Astringent

Oxidized Regenerated Cellulose Based Astringent

Combination Astringent

Gelatin-based Astringent

Collagen-based Astringent

Regional Insights

Loading chart…

Asia Pacific dominates the astringent market growth, capturing 42% of 2024 global value, propelled by China and India’s surging skincare investment, Gen-Z demographics exceeding 600 million, and accelerated e-commerce infrastructure maturity. North America (28%) remains the premium innovation hub where FDA-cleared clean-label formulations, high per-capita spending and dermo-cosmetic clinic adoption sustain a resilient regional forecast CAGR of 6.1%.

Europe (20%) benefits from the EU Green Deal incentives, recyclable packaging mandates and a well-established pharmacy channel, while Latin America (6%) leverages Brazil’s medical tourism policies and rising dermal health awareness to post the fastest regional forecast expansion at 8.4% CAGR. Middle East & Africa (4%) is scaling through Saudi Vision 2030 beauty-sector incentives, halal-certification alignment and an influx of Korean formulation joint ventures.

Key regional drivers5 items

Asia Pacific: Rising disposable income, K-beauty spill-over, 5G-enabled social commerce

North America: Insurance-backed dermatology visits, OTC monograph clarity, start-up funding

Europe: Circular-economy subsidies, cruelty-free legislation, cross-border e-pharmacy

Latin America: Government telehealth programs, influencer marketing, mineral-rich botanical sourcing

MEA: Tax-free cosmetic zones, medical spa infrastructure build-outs, youthful population pyramid

Competitive Landscape

The astringent competitive landscape is moderately consolidated: a handful of global med-tech and pharma incumbents control regulatory dossiers and hospital tenders, while dozens of regional firms compete on price in outpatient and retail segments. Competitive levers are split—multinationals rely on clinical evidence, reimbursement approvals, and multi-channel distribution, whereas local players emphasize cost leadership, customized pack sizes, and faster regulatory turnaround in emerging markets.

To offset margin pressure from commoditized aluminum chloride and hemostatic formulations, suppliers pursue vertical integration, tactical M&A, and indication-specific R&D (e.g., combining astringency with sealants for endoscopic procedures). Differentiation increasingly hinges on bioresorbable polymers, patented applicators, and value-added services such as compliance training, while compliance costs for ISO 13485 and MDR updates compress gross margins across the value chain.

Companies Strategy Snapshot6 items

Ethicon prioritizes innovation pipeline in next-gen absorbable hemostats

Pfizer leverages premium pricing coupled with global tender alliances

Baxter International targets regional expansion through local manufacturing hubs

C. R. Bard focuses on vertical integration of astringent-soaked dressings

Anika Therapeutics emphasizes OEM tie-ups for combination astringent-hyaluronic products

Integra LifeSciences invests in clinical evidence to support regulatory dossiers

Market Ecosystem

By paragraph, using: following,, in, by the

Recent Industry Insights

Astringent industry trends over the past 18 months have been shaped by clean-beauty acceleration and post-biotic science. In March 2024, L'Oréal acquired probiotic-astringent start-up MicroBalans to fold live-bacteria pore-tightening serums into its Active Cosmetics division, forecasting first-to-market derm-biotic toners by 2025. Meanwhile, Kao USA and micro-biome research hub SkinBioTherapeutics formed a JDA to screen plant-derived tannins that selectively inhibit acne-associated Cutibacterium without disrupting skin commensals, aiming for OTC-monograph clearance in the U.S. by Q4 2025.

Regulators are tightening alcohol limits: the EU Commission revised the Cosmetic Regulation in late 2023, capping denatured alcohol at 15% in leave-on astringents, a move that pushed Beiersdorf to replace ethanol with fermented witch-hazel water across its NIVEA Men line this spring. On-shelf, waterless concentrate sticks grew 38% in prestige U.S. outlets (NPD, 2024 Q1), as Gen-Z buyers seek low-carbon formats. To meet demand, Clarins Group raised €60m in green-linked loans to retrofit its Pontoise plant for solid astringent serum sticks, targeting a 30% carbon-intensity cut by 2026.

Looking ahead, expect AI-guided personalization—Sephora USA’s 2024 pilot kiosks formulate on-the-spot astringent pads based on real-time sebum scans, and venture funding for similar start-ups topped $120m year-to-date, signaling a tech-enabled inflection point.

Analyst Overview

The astringent market outlook points to a structurally attractive arena: mid-single-digit volume growth, resilient 4–5 % price escalators, and penetration upside in Asia-Pacific personal-care and OTC dermatology. Competitive intensity is moderate—the top-five formulators control <40 % share, leaving room for nimble independents to scale via niche actives and clean-label positioning.

Long-term fundamentals rest on three pillars: aging consumers prioritizing pore-minimizing efficacy, clinical data validating polyphenol-rich botanicals, and tightening micro-plastic regulations that favor biodegradable astringent films. Innovation is migrating from simple alcohol-based toners to bio-fermented acids, time-release encapsulates, and microbiome-friendly actives—patent filings have doubled since 2019.

Demand-supply is balanced through 2027; however, witch-hazel and oak gall harvest volatility could tighten feedstock in 2025-26. Key risks include EU allergen labeling revisions, currency swings in emerging markets, and consumer backlash against "over-drying" alcohol systems. Portfolio hedging, dual sourcing of botanicals, and transparent efficacy claims are critical for sustained share capture.

12 items

1. Executive Summary

2. astringent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global astringent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global astringent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global astringent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global astringent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global astringent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global astringent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global astringent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global astringent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global astringent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global astringent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global astringent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global astringent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global astringent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global astringent Market Competition by Key Manufacturers

9.1. Global astringent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global astringent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Ethicon

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Pfizer

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Baxter International

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. C. R. Bard

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. The Medicines Company

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Anika Therapeutics

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Advanced Medical Solutions

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Integra LifeSciences

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. B Braun Melsungen

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Gelita Medical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Equimedical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Vascular Solutions

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Marine Polymer Technologies

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Z-Medica

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. CryoLife

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. BioCer Entwicklungs

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Biom’Up SAS

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global astringent Market

Figure 4: Global astringent Market: Drivers

Figure 5: Global astringent Market: Challenges

Figure 6: Global astringent Market: Trends

Figure 7: Global astringent Market: Opportunity

Figure 8: Global astringent Market: Restraint

Figure 9: Global astringent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global astringent Market Value (USD Million) By Region

Figure 19: Global astringent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global astringent Market Value (USD Million) By Region

Figure 27: Global astringent Market Share (%) By: Regions (2032)

Figure 28: Global astringent Market Volume (K) By Region

Figure 29: Global astringent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global astringent Market Value (USD Million) By Region

Figure 37: Global astringent Market Share (%) By: Regions (2032)

Figure 38: Global astringent Market Volume (K) By Region

Figure 39: Global astringent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global astringent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global astringent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global astringent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global astringent Market Value (USD Million) By Region

Table 14: Global astringent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global astringent Market Volume (K) By Region

Table 31: Global astringent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global astringent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global astringent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global astringent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Ethicon Basic Information And Sales Area

Table 52: Ethicon. Products Portfolio

Table 53: Pfizer Basic Information And Sales Area

Table 54: Pfizer. Products Portfolio

Table 55: Baxter International Basic Information And Sales Area

Table 56: Baxter International. Products Portfolio

Table 57: C. R. Bard Basic Information And Sales Area

Table 58: C. R. Bard. Products Portfolio

Table 59: The Medicines Company Basic Information And Sales Area

Table 60: The Medicines Company. Products Portfolio

Table 61: Anika Therapeutics Basic Information And Sales Area

Table 62: Anika Therapeutics. Products Portfolio

Table 63: Advanced Medical Solutions Basic Information And Sales Area

Table 64: Advanced Medical Solutions. Products Portfolio

Table 65: Integra LifeSciences Basic Information And Sales Area

Table 66: Integra LifeSciences. Products Portfolio

Table 67: B Braun Melsungen Basic Information And Sales Area

Table 68: B Braun Melsungen. Products Portfolio

Table 69: Gelita Medical Basic Information And Sales Area

Table 70: Gelita Medical. Products Portfolio

Table 71: Equimedical Basic Information And Sales Area

Table 72: Equimedical. Products Portfolio

Table 73: Vascular Solutions Basic Information And Sales Area

Table 74: Vascular Solutions. Products Portfolio

Table 75: Marine Polymer Technologies Basic Information And Sales Area

Table 76: Marine Polymer Technologies. Products Portfolio

Table 77: Z-Medica Basic Information And Sales Area

Table 78: Z-Medica. Products Portfolio

Table 79: CryoLife Basic Information And Sales Area

Table 80: CryoLife. Products Portfolio

Table 81: BioCer Entwicklungs Basic Information And Sales Area

Table 82: BioCer Entwicklungs. Products Portfolio

Table 83: Biom’Up SAS Basic Information And Sales Area

Table 84: Biom’Up SAS. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global astringent Market Value (USD Million) By Region

Table 94: Global astringent Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global astringent Market Volume (K) By Region

Table 111: Global astringent Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

astringent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 million
Revenue forecast in 2033	3.15 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ethicon; Pfizer; Baxter International; C. R. Bard; The Medicines Company; Anika Therapeutics; Advanced Medical Solutions; Integra LifeSciences; B Braun Melsungen; Gelita Medical; Equimedical; Vascular Solutions; Marine Polymer Technologies; Z-Medica; CryoLife; BioCer Entwicklungs; Biom’Up SAS
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Restraints

Opportunities

Challenges

Market Segmentation

Loading chart…

astringent Segmentation Breakdown10 items

Application

Hospitals

Surgical Centers

Nursing Homes

Types

Thrombin-based Astringent

Oxidized Regenerated Cellulose Based Astringent

Combination Astringent

Gelatin-based Astringent

Collagen-based Astringent

Regional Insights

Loading chart…

Key regional drivers5 items

Asia Pacific: Rising disposable income, K-beauty spill-over, 5G-enabled social commerce

North America: Insurance-backed dermatology visits, OTC monograph clarity, start-up funding

Europe: Circular-economy subsidies, cruelty-free legislation, cross-border e-pharmacy

Latin America: Government telehealth programs, influencer marketing, mineral-rich botanical sourcing

MEA: Tax-free cosmetic zones, medical spa infrastructure build-outs, youthful population pyramid

Competitive Landscape

Companies Strategy Snapshot6 items

Ethicon prioritizes innovation pipeline in next-gen absorbable hemostats

Pfizer leverages premium pricing coupled with global tender alliances

Baxter International targets regional expansion through local manufacturing hubs

C. R. Bard focuses on vertical integration of astringent-soaked dressings

Anika Therapeutics emphasizes OEM tie-ups for combination astringent-hyaluronic products

Integra LifeSciences invests in clinical evidence to support regulatory dossiers

Recent Industry Insights

Analyst Overview

Table of Contents